|Vaccination Liberation - Information|
Ingredients of Vaccines
Artificially Sweetened Times
Books Videos Tapes
100+ Anti-Vax links
CanadaGBS Reports following Gardasil vaccination.
VRAN - Vaccination Risk Awareness Network
September 12, 2007
Dear VRAN Members & Friends,
As a steadily growing number of provinces commit scarce health care resources to the vaccination of young girls with Gardasil, the heavily promoted “cervical cancer vaccine”, the public is still in the dark about the risks and side effects now associated with and documented on this vaccine. Nor is the public aware of the absence of fundamental safe guards in this country. Canada has NO “mandatory” reporting system of vaccine reactions, and NO publicly accessible data base of reactions/injuries which could be scrutinized to track the type and degree of injuries inflicted by this new vaccine on young girls.
Ontario is fast tracking Gardasil and lining up all grade 8 girls starting now, this September. The first group of 85,000 teenage girls will get the first series of 3 shots at a cost of approx. $400 each for a staggering $34 million in that province alone, to be repeated year in and year out. The cost of the vaccine doesn’t include the cost of administration and infrastructure required to implement it in the province.
As with all other vaccines injected into Canadian children, when families agree to allow their daughters to partake in this medical experimentation, they will have no recourse when reactions and injuries occur, nor will they have any idea the numbers of girls adversely effected in this county. Based on reports to the U.S. VAERS reporting system, that health damage from this vaccine will occur is a certainty. We can only extrapolate from the U.S. experience the degree and types of injuries we can expect. Remember the figures provided below by consumer watchdog group NVIC, the injuries reported are only the tip of the iceberg as only 1% to 10% of vaccine reactions and injuries are reported to this federal data base.
We appreciate the vigilance of NVIC and for their diligent efforts to inform the world of the fallout from this latest medical experimentation foisted on the people.
NVIC Analysis Shows Greater Risk of GBS Reports When HPV Vaccine Is Given with Meningococcal and Other Vaccines
Washington, August 15, 2007 - The National Vaccine Information Center (NVIC) today issued a new report on HPV vaccine (Gardasil®) safety analyzing adverse event reports to the federal Vaccine Adverse Event Reporting System (VAERS). The analysis gives evidence for a reported association in VAERS between Gardasil and Guillain-Barre Syndrome (GBS), with a statistically significant increased risk of GBS and other serious adverse event reports when Gardasil is co- administered with other vaccines, especially meningococcal vaccine (Menactra®).
NVIC is calling on the Centers for Disease Control (CDC) to issue an Advisory and amend its March 12 policy by alerting the public that Gardasil has been associated with 15 cases of GBS and an increased risk of GBS and other serious adverse event reports made to VAERS when the vaccine is administered simultaneously with Menactra and other vaccines. "The precautionary principle dictates that good science should precede CDC vaccine policy recommendations," said Barbara Loe Fisher, NVIC co- founder and president. "Parents have a right to expect proof of safety and not assumption of safety before new vaccines, like Gardasil, are given simultaneously with other vaccines to their children.
GBS is a disorder in which the body's immune system attacks part of the peripheral nervous system, and can cause total paralysis. "Our analysis of Gardasil reports to VAERS indicates there was a two to 12 times greater likelihood that serious adverse events, such as GBS, were reported when Gardasil was given in combination with Menactra rather than given alone," said Vicky Debold, PhD, RN, NVIC director of patient safety. "Accepted scientific standards indicate that these findings are statistically significant and cannot be dismissed as coincidence. In particular, the available VAERS data show there was a more than 1,000 percent increased risk of GBS reports following Gardasil administration when Menactra was given at the same time."
Reported GBS and Other Serious Adverse Events
NVIC found that, as of May 31, there have been 2,227 Gardasil adverse events filed with VAERS, including 13 suspected or confirmed cases of GBS (two more GBS reports were made in June for a total of 15) and 239 cases of syncope (fainting with temporary loss of consciousness), many of which resulted in head injuries and fractures. Seven deaths have been reported after receipt of Gardasil. Nearly 10 percent of all Gardasil adverse event reports to VAERS involved avoidable medical errors.
A total of 1,930 reported Gardasil adverse events involved administration of Gardasil alone, and 135 adverse events involved co-administration of Gardasil with Menactra. NVIC's comparative analysis of those two categories of VAERS reports indicates that when Gardasil was given simultaneously with Menactra rather than alone, there was a statistically significant increased risk of reported adverse events:
-respiratory problem reports increased by 114 percent;
On February 21, NVIC expressed concern about the safety of administering Gardasil simultaneously with other vaccines because the manufacturer (Merck), the FDA and the CDC had not provided evidence to the public that co-administration was safe. (1) On March 12, the CDC published recommendations for Gardasil use in MMWR that acknowledged there is a lack of evidence that Gardasil can be safely administered with other vaccines, while encouraging physicians to co- administer Menactra and other vaccines with Gardasil based on assumption of safety. (2)
Adverse Event Reports to NVIC: Shannon Nelson
Nineteen Gardasil adverse event reports from 12 states have been made to NVIC's Vaccine Reaction Registry involving unconsciousness and injury, convulsions, numbness, weakness and other neuromuscular and coordination problems and GBS.
Shannon Nelson, 18, a Chicago area athlete, musician and artist entering college reported to NVIC that she received HPV vaccine (Gardasil), meningococcal vaccine (Menactra) and chicken pox vaccine (Varivax ®) simultaneously on June 21. Symptoms of tingling, numbness and muscle weakness began within a week and progressively got worse. By July 3 she could barely walk or raise her arms. She was hospitalized, paralyzed with GBS on July 5, and spent 22 days in the hospital.
"Before the shots, I ran six miles a day," said Nelson. "The doctors told me that I might have been put on a respirator if I hadn't been in such good shape," she said. "I am out of the hospital now and getting a lot of physical therapy. I just want to go to college and do the things I did before, like play the guitar and draw or even just be able to smile. My Mom and I wish we had known about HPV vaccine risks, especially what could happen if I got other vaccines at the same time."
To view a copy of NVIC's report on HPV vaccine (Gardasil) safety, go to http://www.nvic.org/Diseases/HPV/HPVHOME.htm.
1) Vaccine Safety Group Releases Gardasil Report: Calls on FDA and CDC to Warn Doctors and Parents to Report to VAERS, February 21, 2007 http://www.nvic.org/Diseases/HPV/pr022107HPV. htm.
2) Centers for Disease Control and Prevention. Quadrivalent Human Papillomavirus Vaccine: Recommendations of ]the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) Early Release 2007; 56 March 12, 2007:1-24. http://www.cdc.gov/mmwr/preview/mmwr html/rr56e312a1.htm.
VRAN is Canada's leading vaccine awareness educational society. We are a not-for-profit group without ties to government or corporations and are solely supported by our members. Learn more about vaccines, diseases and how to protect your children from vaccine induced injuries. Become a member of VRAN and receive our internationally acclaimed newsletters www.vran.org